Immediate Impact
1 by Nobel laureates 2 from Science/Nature 67 standout
Citing Papers
Cancer incidence and mortality in China, 2022
2024 Standout
Thyroid Cancer
2024 Standout
Works of Roger Allison being referenced
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
2015
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Roger Allison | 444 | 435 | 188 | 28 | 1.1k | |
| Agnese Barnabei | 684 | 347 | 173 | 35 | 1.2k | |
| Gilles Chaplain | 444 | 271 | 256 | 33 | 1.2k | |
| Myles P. Cunningham | 389 | 443 | 229 | 22 | 1.0k | |
| Aaron Brown | 234 | 343 | 359 | 30 | 1.2k | |
| Anne‐Laure Giraudet | 219 | 688 | 224 | 50 | 1.3k | |
| J.E. Couette | 207 | 474 | 156 | 16 | 949 | |
| Barbara K. Kinder | 357 | 360 | 134 | 34 | 953 | |
| James P. O'Brien | 451 | 229 | 190 | 35 | 1.2k | |
| C. C. Zielinski | 259 | 131 | 152 | 45 | 907 | |
| Debora Formisano | 176 | 421 | 369 | 35 | 1.2k |
All Works
Loading papers...